Lyle L. Sensenbrenner

2.1k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Lyle L. Sensenbrenner is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Lyle L. Sensenbrenner has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Oncology and 9 papers in Immunology. Recurrent topics in Lyle L. Sensenbrenner's work include Hematopoietic Stem Cell Transplantation (13 papers), Polyomavirus and related diseases (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Lyle L. Sensenbrenner is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Polyomavirus and related diseases (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Lyle L. Sensenbrenner collaborates with scholars based in United States, Peru and Pakistan. Lyle L. Sensenbrenner's co-authors include George W. Santos, Robert K. Stuart, William H. Burns, Andrew M. Yeager, Hayden G. Braine, Herbert Kaizer, Rein Saral, Wilma Β. Bias, Ronald Brookmeyer and David Mellits and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Cancer.

In The Last Decade

Lyle L. Sensenbrenner

28 papers receiving 1.5k citations

Hit Papers

Marrow Transplantation for Acute Nonlymphocytic Leukemia ... 1983 2026 1997 2011 1983 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyle L. Sensenbrenner United States 15 1.1k 444 297 292 252 28 1.6k
J Treleaven United Kingdom 28 1.1k 1.1× 515 1.2× 334 1.1× 313 1.1× 397 1.6× 71 2.0k
LL Sensenbrenner United States 24 1.2k 1.2× 500 1.1× 143 0.5× 525 1.8× 376 1.5× 67 2.0k
Shinjiro Todo Japan 21 721 0.7× 236 0.5× 213 0.7× 444 1.5× 258 1.0× 79 1.4k
Akira Tomonari Japan 20 1.0k 1.0× 465 1.0× 149 0.5× 269 0.9× 274 1.1× 72 1.6k
G Isacchi Italy 20 685 0.6× 241 0.5× 170 0.6× 413 1.4× 440 1.7× 75 1.6k
H Rochant France 26 978 0.9× 183 0.4× 161 0.5× 336 1.2× 604 2.4× 107 1.9k
Zalmen A. Arlin United States 19 577 0.5× 336 0.8× 345 1.2× 75 0.3× 303 1.2× 53 1.1k
Heike Engel United States 15 683 0.6× 345 0.8× 118 0.4× 512 1.8× 211 0.8× 25 1.3k
Y Carcassonne France 17 399 0.4× 278 0.6× 177 0.6× 134 0.5× 179 0.7× 115 1.1k
Miloslav Beran United States 26 1.5k 1.5× 483 1.1× 347 1.2× 356 1.2× 897 3.6× 81 2.5k

Countries citing papers authored by Lyle L. Sensenbrenner

Since Specialization
Citations

This map shows the geographic impact of Lyle L. Sensenbrenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyle L. Sensenbrenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyle L. Sensenbrenner more than expected).

Fields of papers citing papers by Lyle L. Sensenbrenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyle L. Sensenbrenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyle L. Sensenbrenner. The network helps show where Lyle L. Sensenbrenner may publish in the future.

Co-authorship network of co-authors of Lyle L. Sensenbrenner

This figure shows the co-authorship network connecting the top 25 collaborators of Lyle L. Sensenbrenner. A scholar is included among the top collaborators of Lyle L. Sensenbrenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyle L. Sensenbrenner. Lyle L. Sensenbrenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkodee-Adoo, C, Lyle L. Sensenbrenner, Aaron P. Rapoport, et al.. (2003). Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion. 43(1). 78–84. 53 indexed citations
2.
Varterasian, Mary, Voravit Ratanatharathorn, Joseph P. Uberti, et al.. (1995). Clinical Course and Outcome of Patients with Hodgkin's Disease who Progress after Autologous Transplantation. Leukemia & lymphoma. 20(1-2). 59–65. 16 indexed citations
3.
Türkeri, Levent N., Lawrence G. Lum, Joseph P. Uberti, et al.. (1995). Prevention of Hemorrhagic Cystitis Following Allogeneic Bone Marrow Transplant Preparative Regimens With Cyclophosphamide and Busulfan. The Journal of Urology. 637–640. 1 indexed citations
5.
Uberti, Joseph P., Voravit Ratanatharathorn, Chatchada Karanes, & Lyle L. Sensenbrenner. (1994). Allogeneic Bone Marrow Transplantation in Patients with Myelodysplastic Syndromes. Leukemia & lymphoma. 14(5-6). 379–385. 5 indexed citations
6.
Mohammad, Ramzi M., Ayad Al‐Katib, George R. Pettit, & Lyle L. Sensenbrenner. (1994). Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.. PubMed. 54(1). 165–8. 47 indexed citations
7.
Baker, Laurence H., J. A. Jones, Lonnie K. Zeltzer, et al.. (1993). Workgroup #3: Psychosocial and emotional issues and specialized support groups and compliance issues. Cancer. 71(7). 2419–2422. 7 indexed citations
8.
Fan, Kai, et al.. (1993). Deregulation of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) receptor in murine macrophage cell line J774A.1. Journal of Cellular Physiology. 154(3). 535–542. 6 indexed citations
9.
Al-Katib, Ayad, Ramzi M. Mohammad, Khalid M. Khan, et al.. (1993). Bryostatin 1-Induced Modulation of the Acute Lymphoblastic Leukemia Cell Line Reh. Journal of Immunotherapy. 14(1). 33–42. 22 indexed citations
10.
Al‐Katib, Ayad, Ramzi M. Mohammad, Anwar N. Mohamed, George R. Pettit, & Lyle L. Sensenbrenner. (1990). Conversion of high grade lymphoma tumor cell line to intermediate grade with tpa and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis. Hematological Oncology. 8(2). 81–89. 14 indexed citations
11.
Linet, Martha S., et al.. (1989). A case-control study of aplastic anemia. Leukemia Research. 13(1). 3–11. 16 indexed citations
12.
Sieber, Fritz, et al.. (1987). ANTIVIRAL ACTIVITY OF MEROCYANINE 540. Photochemistry and Photobiology. 46(5). 707–711. 62 indexed citations
13.
Skelly, R R, et al.. (1987). Neuropeptide modulation of murine erythropoiesis.. PubMed. 17(5). 324–30. 4 indexed citations
15.
Linet, Martha S., et al.. (1986). Incidence of aplastic anemia in a three county area in South Carolina.. PubMed. 46(1). 426–9. 10 indexed citations
16.
Anderson, Kenneth C., Richard L. Humphrey, & Lyle L. Sensenbrenner. (1983). Predictive values of the in vivo diffusion chamber for cyclophosphamide treatment of L1210 murine leukemia.. PubMed. 43(5). 2030–3. 4 indexed citations
17.
Stuart, Robert K., Lyle L. Sensenbrenner, Richard K. Shadduck, Abdül Waheed, & Cecilia Caramatti. (1983). Phorbol ester‐stimulated murine myelopoiesis: Role of colony‐stimulating factors. Journal of Cellular Physiology. 117(1). 30–38. 8 indexed citations
18.
Pitha, Paula M., et al.. (1978). Polymeric Drugs: Direct Compared with Indirect Inhibition of Leukemia Virus Replication in Mice. Molecular Pharmacology. 14(2). 271–277. 1 indexed citations
19.
Borden, Ernest C., William A. Carter, Lyle L. Sensenbrenner, et al.. (1974). Inhibition by streptovaricins of rauscher leukemia virus splenomegaly. International Journal of Cancer. 14(6). 817–825. 2 indexed citations
20.
Santos, George W., Albert H. Owens, & Lyle L. Sensenbrenner. (1964). EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ANTIBODY PRODUCTION IN MAN; A PRELIMINARY REPORT*. Annals of the New York Academy of Sciences. 114(1). 404–423. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026